Johnson & Johnson officer proposes $3.72M share sale

Available on EDGAR 11/12/2026 - 10:00 AM EST Accepted by SEC EDGAR 11/12/2026 - 10:00 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Johnson & Johnson (JNJ) officer Elizabeth Forminard is named in a notice of a proposed sale of 13,072 common shares, with an aggregate market value of $3,717,546.08 and an approximate sale date of November 12, 2026. The notice also lists acquisition of 13,072 shares from the issuer through a stock option exercise on November 12, 2026, with cash as the payment. Fidelity Brokerage Services LLC is named as broker.

Key Figures

Common shares proposed for sale: 13,072 shares Aggregate market value: $3,717,546.08 Shares outstanding: 2,407,310,266 shares +1 more

4 metrics

Common shares proposed for sale 13,072 shares Approximate sale date November 12, 2026

Aggregate market value $3,717,546.08 Proposed sale of 13,072 common shares

Shares outstanding 2,407,310,266 shares Reported in the notice

Shares acquired through stock option exercise 13,072 shares Acquired from the issuer on November 12, 2026; payment was cash

Key Terms

Stock Option Exercise

1 terms

Stock Option Exercise financial

"acquired through a stock option exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JNJ shares did officer Elizabeth Forminard propose to sell?

Elizabeth Forminard's notice lists a proposed sale of 13,072 JNJ common shares, with an aggregate market value of $3,717,546.08.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001950802
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JOHNSON & JOHNSON
SEC File Number	001-03215
Address of Issuer	ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NEW JERSEY 08933
Phone	732-524-2455
Name of Person for Whose Account the Securities are To Be Sold	Forminard Elizabeth
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13072	3717546.08	2407310266	11/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/12/2026	Stock Option Exercise	Issuer			13072	11/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Elizabeth Forminard
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)